• Chỉ định điều trị và tác dụng phụ của truyền khối hồng cầu

      08-10-17, 11:10
      Chỉ định điều trị và tác dụng phụ của truyền khối hồng cầu
      Quay lại: Chỉ định điều trị và tác dụng phụ của truyền khối hồng cầu

      1. Carson JL, Stanworth SJ, Roubinian N, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2016;10:CD002042-CD002042
      2. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-417
      3. Lacroix J, Hébert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007;356:1609-1619
      4. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453-2462
      5. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:11-21
      6. Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371:1381-1391
      7. Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015;372:997-1008
      8. Carson JL, Sieber F, Cook DR, et al. Liberal versus restrictive blood transfusion strategy: 3-year survival and cause of death results from the FOCUS randomised controlled trial. Lancet 2015;385:1183-1189
      9. Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. JAMA 2016;316:2025-2035
      10. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-1060
      11. Shander A, Javidroozi M, Naqvi S, et al. An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion (CME). Transfusion 2014;54:2688-2695
      12. Carson JL, Brooks MM, Abbott JD, et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013;165:964-971.e1
      13. Jairath V, Kahan BC, Gray A, et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015;386:137-144
      14. Docherty AB, O’Donnell R, Brunskill S, et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. BMJ 2016;352:i1351-i1351
      15. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg 1986;73:783-785
      16. Blood transfusion. London: NICE (National Institute for Health and Care Excellence), 2015 (https://www.nice.org.uk/guidance/ng24).
      17. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015;122:241-275
      18. Killick SB, Carter C, Culligan D, et al. Guidelines for the diagnosis and management of adult myelodysplastic syndromes. Br J Haematol 2014;164:503-525
      19. NCCN clinical practice guidelines in oncology: cancer- and chemotherapy-induced anemia. Fort Washington, PA: National Comprehensive Cancer Network, 2013.
      20. Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2013;159:770-779
      21. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228
      22. Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol 2013;160:445-464
      23. Patient blood management guidelines. Lyneham, ACT: National Blood Authority Australia, 2012 (http://www.blood.gov.au/pbm-guidelines).
      24. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012;2:279-335
      25. Van Remoortel H, De Buck E, Dieltjens T, Pauwels NS, Compernolle V, Vandekerckhove P. Methodologic quality assessment of red blood cell transfusion guidelines and the evidence base of more restrictive transfusion thresholds. Transfusion 2016;56:472-480
      26. Alexander J, Cifu AS. Transfusion of red blood cells. JAMA 2016;316:2038-2039
      27. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol 2011;108:1108-1111
      28. Whitaker B, Rajbhandary S, Kleinman S, Harris A, Kamani N. Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey. Transfusion 2016;56:2173-2183
      29. Chung KW, Basavaraju SV, Mu Y, et al. Declining blood collection and utilization in the United States. Transfusion 2016;56:2184-2192
      30. Ellingson KD, Sapiano MRP, Haass KA, et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion 2017;57:Suppl 2:1588-1598
      31. Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017;57:1347-1358
      32. Goodnough LT, Shander A. Patient blood management. Anesthesiology 2012;116:1367-1376
      33. The collection, testing and use of blood and blood components in Europe. 2013 report. Strasbourg, France: Council of Europe, European Directorate for the Quality of Medicines & Healthcare, 2016 (https://www.edqm.eu/sites/default/fi...urope_2013.pdf).
      34. PlaneCrashInfo.com. Causes of fatal accidents by decade. 2017 (http://www.planecrashinfo.com/cause.htm).
      35. National Weather Service. How dangerous is lightning? 2017 (http://www.lightningsafety.noaa.gov/odds.shtml).
      36. Miniño AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep 2011;59:1-126
      37. Kohn L. To err is human: an interview with the Institute of Medicine’s Linda Kohn. Jt Comm J Qual Improv 2000;26:227-234
      38. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-1504
      39. Aberle-Grasse J, Orton SL, Notari E IV, et al. Predictive value of past and current screening tests for syphilis in blood donors: changing from a rapid plasma reagin test to an automated specific treponemal test for screening. Transfusion 1999;39:206-211
      40. Stramer SL, Wend U, Candotti D, et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 2011;364:236-247
      41. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid–amplification testing. N Engl J Med 2004;351:760-768
      42. Ness PM, Nass CC. Blood donor testing for HIV-I/II and HTLV-I/II. Arch Pathol Lab Med 1994;118:337-341
      43. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005;353:460-467
      44. Cantey PT, Stramer SL, Townsend RL, et al. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion 2012;52:1922-1930
      45. Katz LM, Rossmann SN. Zika and the blood supply: a work in progress. Arch Pathol Lab Med 2017;141:85-92
      46. Blajchman MA, Goldman M, Freedman JJ, Sher GD. Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. Transfus Med Rev 2001;15:1-20
      47. Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005;18:195-204
      48. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001;344:1973-1978
      49. Bloch EM, Levin AE, Williamson PC, et al. A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors. Transfusion 2016;56:1875-1882
      50. Moritz ED, Winton CS, Tonnetti L, et al. Screening for Babesia microti in the U.S. blood supply. N Engl J Med 2016;375:2236-2245
      51. Fang DC, McCullough J. Transfusion-transmitted Babesia microti. Transfus Med Rev 2016;30:132-138
      52. Stramer SL, Linnen JM, Carrick JM, et al. Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012;52:1657-1666
      53. Petersen LR, Stramer SL, Powers AM. Chikungunya virus: possible impact on transfusion medicine. Transfus Med Rev 2010;24:15-21
      54. Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N Engl J Med 2012;367:1237-1244
      55. McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004;104:1534-1541
      56. Prowse CV. Component pathogen inactivation: a critical review. Vox Sang 2013;104:183-199
      57. Allain JP, Owusu-Ofori AK, Assennato SM, Marschner S, Goodrich RP, Owusu-Ofori S. Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet 2016;387:1753-1761
      58. Roubinian NH, Hendrickson JE, Triulzi DJ, et al. Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm. Vox Sang 2017;112:56-63
      59. Narick C, Triulzi DJ, Yazer MH. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012;52:160-165
      60. Blood safety surveillance. Atlanta: Centers for Disease Control and Prevention, 2009 (https://www.cdc.gov/nhsn/acute-care-hospital/bio-hemo/).
      61. Transfusion-associated circulatory overload (TACO) 2014 revision. London: International Society of Blood Transfusion Working Party on Haemovigilance, International Haemovigilance Network, December 2014 (http://www.isbtweb.org/fileadmin/use...ovigilance.pdf).
      62. Roubinian NH, Murphy EL. Transfusion-associated circulatory overload (TACO): prevention, management, and patient outcomes. Int J Clin Transfus Med 2015;3:17-28
      63. Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44:1774-1789
      64. Toy P, Gajic O, Bacchetti P, et al. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012;119:1757-1767
      65. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721-726
      66. Müller MC, van Stein D, Binnekade JM, van Rhenen DJ, Vlaar AP. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis. Transfusion 2015;55:164-175
      67. Fatalities reported to FDA following blood collection and transfusion: annual summary for FY2015. Silver Spring, MD: Food and Drug Administration (https://www.fda.gov/downloads/Biolog.../UCM518148.pdf).
      68. Davenport RD, Bluth MH. Hemolytic transfusion reactions. In: Simon TL, McCullough J, Snyder EL, Solheim BG, Strauss RG, eds. Rossi’s principles of transfusion medicine. 5th ed. West Sussex, United Kingdom: Wiley-Blackwell, 2016:642-51.
      69. Transfusion/donation fatalities: notification process for transfusion related fatalities and donation related deaths. Silver Spring, MD: Food and Drug Administration (http://www.fda.gov/BiologicsBloodVac...ionFatalities/).
      70. Hoffbrand AV, Taher A, Cappellini MD. How I treat transfusional iron overload. Blood 2012;120:3657-3669
      71. Vamvakas EC, Bordin JO, Blajchman MA. Immunomodulatory and pro-inflammatory effects of allogeneic blood transfusion. In: Simon TL, McCullough JM, Snyder E, Solheim BG, Strauss RG, eds. Rossi’s principles of transfusion medicine. 5th ed. West Sussex, United Kingdom: Wiley-Blackwell, 2016:695-710.
      72Elmer J, Wilcox SR, Raja AS. Massive transfusion in traumatic shock. J Emerg Med 2013;44:829-838
      73. Cohn SM, Nathens AB, Moore FA, et al. Tissue oxygen saturation predicts the development of organ dysfunction during traumatic shock resuscitation. J Trauma 2007;62:44-55
      74. Murkin JM, Arango M. Near-infrared spectroscopy as an index of brain and tissue oxygenation. Br J Anaesth 2009;103:Suppl 1:i3-i13
      75. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Effect of transfusion of red blood cells with longer vs shorter storage duration on elevated blood lactate levels in children with severe anemia: the TOTAL randomized clinical trial. JAMA 2015;314:2514-2523
      76. Dhabangi A, Ainomugisha B, Cserti-Gazdewich C, et al. Cerebral oximetry in Ugandan children with severe anemia: clinical categories and response to transfusion. JAMA Pediatr 2016;170:995-1002
      77. Alayash AI. Blood substitutes: why haven’t we been more successful? Trends Biotechnol 2014;32:177-185
      78. Abuchowski A. PEGylated bovine carboxyhemoglobin (SANGUINATE): results of clinical safety testing and use in patients. Adv Exp Med Biol 2016;876:461-467
      79. Migliaccio AR, Masselli E, Varricchio L, Whitsett C. Ex-vivo expansion of red blood cells: how real for transfusion in humans? Blood Rev 2012;26:81-95
      80. Giarratana MC, Rouard H, Dumont A, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 2011;118:5071-5079
      Comments Leave Comment

      Click here to log in

      Tin khác
    • Đọc nhiều